Burns J W & CO Inc Gilead Sciences, Inc. Transaction History

Burns J W & CO Inc

$767 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 08, 2022	SELL	$57.92 - $72.58 $605,553 - $758,823	-10,455 Closed	0 $0
Q4 2021 Jan 20, 2022	SELL	$64.88 - $73.64 $32,439 - $36,820	-500 Reduced 4.56%	10,455 $759,000
Q3 2021 Oct 13, 2021	SELL	$67.69 - $73.03 $3,384 - $3,651	-50 Reduced 0.45%	10,955 $765,000
Q2 2021 Jul 12, 2021	SELL	$63.47 - $69.35 $23,801 - $26,006	-375 Reduced 3.3%	11,005 $758,000
Q1 2021 Apr 16, 2021	BUY	$60.0 - $68.46 $300 - $342	5 Added 0.04%	11,380 $735,000
Q4 2020 Jan 12, 2021	BUY	$56.65 - $64.55 $14,162 - $16,137	250 Added 2.25%	11,375 $663,000
Q3 2020 Oct 06, 2020	BUY	$62.1 - $78.08 $1,552 - $1,952	25 Added 0.23%	11,125 $703,000
Q2 2020 Jul 06, 2020	SELL	$72.34 - $84.0 $28,936 - $33,600	-400 Reduced 3.48%	11,100 $854,000
Q1 2020 Apr 06, 2020	BUY	$62.63 - $80.22 $9,394 - $12,033	150 Added 1.32%	11,500 $860,000
Q4 2019 Jan 07, 2020	SELL	$61.62 - $67.78 $36,725 - $40,396	-596 Reduced 4.99%	11,350 $738,000
Q3 2019 Oct 11, 2019	SELL	$62.51 - $69.0 $245,789 - $271,308	-3,932 Reduced 24.76%	11,946 $757,000
Q2 2019 Jul 09, 2019	SELL	$61.87 - $69.38 $136,485 - $153,052	-2,206 Reduced 12.2%	15,878 $1.07 Million
Q1 2019 Apr 02, 2019	SELL	$62.53 - $70.05 $205,473 - $230,184	-3,286 Reduced 15.38%	18,084 $1.18 Million
Q4 2018 Jan 16, 2019	SELL	$60.54 - $79.0 $201,900 - $263,465	-3,335 Reduced 13.5%	21,370 $1.34 Million
Q3 2018 Oct 05, 2018	SELL	$71.28 - $78.92 $33,644 - $37,250	-472 Reduced 1.87%	24,705 $1.91 Million
Q2 2018 Jul 20, 2018	SELL	$64.88 - $75.68 $72,535 - $84,610	-1,118 Reduced 4.25%	25,177 $1.78 Million
Q1 2018 Apr 04, 2018	SELL	$72.84 - $88.8 $27,023 - $32,944	-371 Reduced 1.39%	26,295 $1.98 Million
Q4 2017 Jan 17, 2018	SELL	$71.15 - $83.52 $113,626 - $133,381	-1,597 Reduced 5.65%	26,666 $1.91 Million
Q3 2017 Oct 10, 2017	BUY	$72.11 - $85.47 $2.04 Million - $2.42 Million	28,263	28,263 $2.29 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burns J W & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Burns J W & CO Inc with notifications on news.

Account